📊 PTN Key Takeaways
Is Palatin Technologies Inc. (PTN) a Good Investment?
Palatin Technologies is facing existential distress with a catastrophic 100% revenue decline YoY and quarterly operating cash burn of $10.8M against only $10.2M in total cash, implying approximately one quarter of liquidity remaining. The company exhibits the hallmarks of fundamental business failure: sustained severe operating losses (-33% margin), negative free cash flow, and complete revenue collapse with no disclosed recovery catalyst.
Palatin Technologies Inc. Key Strengths (PTN)
- Zero long-term debt and clean balance sheet structure
- Maintains $10.2M cash position providing near-term liquidity buffer
- Current ratio of 5.04x indicates adequate short-term payment capacity for immediate obligations
PTN Stock Risks: Palatin Technologies Inc. Investment Risks
- Complete revenue annihilation (100% YoY decline) signals catastrophic business deterioration or loss of primary revenue source
- Operating cash burn of $10.8M quarterly against $10.2M total cash position indicates approximately 1 quarter survival window
- Sustained negative profitability with -31.2% net margin and no visible path to breakeven
- Pharmaceutical sector exposure with apparent product pipeline or regulatory failures
- Zero insider buying activity in last 90 days during distressed conditions indicates management loss of confidence
Key Metrics to Watch
- Monthly cash burn rate and total cash depletion timeline
- Revenue stabilization or emergence of new commercial products
- Operating cash flow quarterly trend and improvement trajectory
- Debt or capital raise announcements (survival mechanism)
- Clinical trial outcomes or regulatory approval updates for pipeline assets
Palatin Technologies Inc. (PTN) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 5.04x current ratio provides a solid financial cushion.
PTN Profit Margin, ROE & Profitability Analysis
PTN vs Healthcare Sector: How Palatin Technologies Inc. Compares
How Palatin Technologies Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Palatin Technologies Inc. Stock Overvalued? PTN Valuation Analysis 2026
Based on fundamental analysis, Palatin Technologies Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Palatin Technologies Inc. Balance Sheet: PTN Debt, Cash & Liquidity
PTN Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Palatin Technologies Inc.'s revenue has grown significantly by 3,706% over the 5-year period, indicating strong business expansion. The most recent EPS of $-101.16 indicates the company is currently unprofitable.
PTN Revenue Growth, EPS Growth & YoY Performance
PTN Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $3.9M | -$1.4M | $-0.37 |
| Q2 2026 | $116.0K | -$2.4M | $-1.47 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Palatin Technologies Inc. Dividends, Buybacks & Capital Allocation
PTN SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Palatin Technologies Inc. (CIK: 0000911216)
📋 Recent SEC Filings
❓ Frequently Asked Questions about PTN
What is the AI rating for PTN?
Palatin Technologies Inc. (PTN) has an AI grade of D with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PTN's key strengths?
Claude: Zero long-term debt and clean balance sheet structure. Maintains $10.2M cash position providing near-term liquidity buffer.
What are the risks of investing in PTN?
Claude: Complete revenue annihilation (100% YoY decline) signals catastrophic business deterioration or loss of primary revenue source. Operating cash burn of $10.8M quarterly against $10.2M total cash position indicates approximately 1 quarter survival window.
What is PTN's revenue and growth?
Palatin Technologies Inc. reported revenue of $12.9M.
Does PTN pay dividends?
Palatin Technologies Inc. does not currently pay dividends.
Where can I find PTN SEC filings?
Official SEC filings for Palatin Technologies Inc. (CIK: 0000911216) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PTN's EPS?
Palatin Technologies Inc. has a diluted EPS of $-1.63.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is PTN's fundamental grade?
Based on our AI fundamental analysis in June 2026, Palatin Technologies Inc. has a D grade with 95% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is PTN stock overvalued or undervalued?
Valuation metrics for PTN: ROE of -37.9% (sector avg: 15%), net margin of -31.2% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is PTN's AI grade for 2026?
Our dual AI analysis gives Palatin Technologies Inc. a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PTN's free cash flow?
Palatin Technologies Inc.'s operating cash flow is $-10.8M, with capital expenditures of $51.3K. FCF margin is -84.6%.
How does PTN compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -31.2% (avg: 12%), ROE -37.9% (avg: 15%), current ratio 5.04 (avg: 2).